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The treatment of cancer with chemotherapeutic agents has made great strides in 
the last few decades but still introduces major systemic side effects. The potent drugs 
needed to kill cancer cells often cause irreparable damage to otherwise healthy organs 
leading to further morbidity and mortality. A therapy with intrinsic selective properties 
and/or an inducible activation has the potential to change the way cancer can be treated. 
Gold nanoparticles (GNPs) are biocompatible and chemically versatile tools that can be 
readily functionalized to serve as molecular vehicles. The ability of these particles to 
strongly absorb light with wavelengths in the therapeutic window combined with the 
heating effect of surface plasmon resonance makes them uniquely suited for noninvasive 
heating in biologic applications. Specially designed DNA aptamers have shown their 
ability to serve as drug carriers through intercalation as well as directly acting as 
therapeutic agents. By combining these separate molecules a multifaceted drug delivery 
vehicle can be created with great potential as a selective and controllable treatment for 
cancer. 
 Oligonucleotide-coated GNPs have been created using spherical GNPs but little 
work has been reported using gold nanoplates in this way. Using the Diasynth method 
gold nanoplates were produced to absorb strongly in the therapeutic near infrared (nIR) 
window. These particles were functionalized with two DNA oligonucleotides: one 
serving as an intercalation site for doxorubicin, and another, AS1411, serving directly as 
an anticancer targeting/therapeutic agent. These functional particles were fully 
synthesized and processed along with confirmation of DNA functionalization and 
doxorubicin intercalation. Doxorubicin is released via denaturation of the DNA structure 
into which doxorubicin is intercalated upon the heating of the gold nanoplate well above 
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the DNA melting temperature. This temperature increase, due to light stimulation of 
surface plasmon resonance, was measured during laser application. Successful release of 
doxorubicin via laser application was measured with fluorescence measurements 
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A. Problem Statement 
Gold nanoparticles (GNPs) have been studied for many years, due to their unique 
optical and physical characteristics, with the vast majority of research being done with gold 
nanospheres, the most common and easily produced particle type. More recently research 
has been done on more complex geometries of GNPs, such as nanoplates, which exhibit 
similar overall characteristics as gold nanospheres but with some outstanding features, such 
as high absorbance in the near-infrared (nIR) region of the electromagnetic spectrum. Due 
to high transmissivity of nIR light through biological media, this feature has proved 
invaluable for targeted photothermal ablation of living tissue with minimal collateral 
damage when targeting cancer cells (Gobin 2010). With the ability to reproducibly 
synthesize a large batch of gold nanoplates, using a technique such as Diasynth (Patel 
2012), the unique therapeutic possibilities of these particles can be explored. 
Conjugation of GNPs with various macromolecules has been studied for the ability 
to provide stability as well as drug delivery options to create versatile platforms for 
biological applications (Delong 2010). One such biomolecule that has become popular for 
this application in recent years is oligonucleotides. The application of DNA/RNA strands 
to create tertiary structures such as stem loops, or hairpins, has also been used 
independently to create biologically compatible drug delivery platforms through 
intercalation of therapeutic agents (Agudelo 2014). These drugs can then be released 
through thermal, chemical, or enzymatic denaturation of the DNA. Still other sequences of 
single stranded DNA, such as the guanosine-rich aptamer AS1411, have been found to 
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have direct therapeutic effects against cancer cells (Stahel 2003, Bates 2009). The method 
of action of AS1411 is through geometric recognition with cell surface proteins only 
present on cancer cells, making AS1411 effectively inert to noncancerous cells. The 
clinical potential of AS1411 has been curtailed through short systemic circulation time. 
By conjugating a hairpin structure to the surface of a gold nanoparticle, thermal 
denaturation can be achieved by heating the gold through application of external light to 
induce localized surface plasmon resonance (Gobin 2010). DNA-functionalization of 
GNPs, intercalation of dox into hairpin DNA, and creation of therapeutic DNA aptamers 
alone have been accomplished. Research has been broad with applications ranging from 
creating higher order supramolecular structures, selective binding of aptamers to cells or 
other DNA, or use as diagnostic marker for biosensing (Song 2010, Delong 2010). Each 
has shown some success as a tool for cancer therapy but not without limitations. A single 
complex combining all of these types of therapeutic modalities has the potential to bring a 
multifaceted approach to cancer therapy. This would include the selective molecular effects 
of the AS1411, the induced drug release of the hairpin, and the thermal effect of the GNPs. 
B. Background 
Cancer has been one of the largest causes of mortality globally and the number of 
cancer cases is continually rising (Bode 2009). Standard treatments for cancer consist of 
either radiation, chemotherapy, or both, which can have devastating side effects (Chabner 
2005). One of the largest drawbacks of chemotherapy is the lack of specificity and 
controllability in the effect of the drug, often leading to dose-limited application that risks 
severe damage to otherwise healthy organs. It is desirable to have a treatment that could be 
deployed such that the active drug would remain sequestered until released via a controlled 
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secondary mechanism, or a drug that exhibits specificity in only damaging the cancerous 
tissue. 
GNPs have been used for decades in biological applications for the detection, 
diagnosis, and treatment of various diseases, utilizing the unique chemical and optical 
properties of nano-sized gold. They can also cover a broad spectrum of sizes, geometries 
(including spheres, rods, and plates), and compositions, each of which has unique 
characteristics. For biological applications GNPs are useful for their small size, 
biocompatibility, and ability to be conjugated easily with other molecules (Delong 2010). 
Sizes of GNPs can range from one nanometer to over 120 nanometers (Boisselier 2009), 
but for therapeutic applications size is most immediately relevant to the ability of the 
particles to reach the desired region in the body. In the case of intravenous cancer treatment 
the minimum size would be directly dependent on the perforations of the endothelium 
providing tumor perfusion (Iyer 2006), which have been shown to be larger in tumor 
vasculature than healthy vessels, a phenomenon referred to as the enhanced permeability 
and retention effect, or EPR.  
The major determining factor for particle geometry is the chemical synthesis and 
resulting composition of the GNPs. Through the reaction of a gold salt, tetrachloroauric 
acid, with sodium thiosulfate in a cellulose acetate dialysis membrane non-spherical gold 
particles can be created in a one-step reaction without the use of seeds or other capping 
agents. Furthermore, using the “Diasynth” method gold nanoplates can be synthesized to 
be tuned to a desired size, directly corresponding to a maximum absorbance wavelength in 
the near-infrared range, by controlling the surface area of cellulose membrane and reaction 
temperature (James 2013, Patel 2012). Gold nanoplates are the main product of this 
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reaction although smaller spherical GNPs are also formed, and can be removed through 
physical separation (Zhang 2012). Generally gold nanoplate dimensions measure from 40 
nm to 1 um edge length and 5 to 50 nm thick with the possibility of truncation of the 
vertices. Synthesis in solution usually produces single crystalline face-centered cubic 
lattices. Edge length, thickness, and truncation all ultimately affect the light extinction 
properties, and are to some degree controllable (Millstone 2009). 
The most important property of GNPs for cancer therapy is a phenomenon known 
as localized surface plasmon resonance, or LSPR. Localized surface plasmon resonance is 
a well-studied ability of colloidal metal particles to vibrate at high frequency when exposed 
to an electromagnetic field. This is caused by the creation of an electric dipole within the 
particle, due to a difference in electron density, causing the particle to oscillate in turn with 
the frequency of the electric field of the incoming light. The application of this effect is 
even further magnified in potential when it is coupled with the near-infrared transparency 
of human skin. The wavelength range from 650 to 950 nm is known as the optical, or 
therapeutic, window for biomedical applications due to the dip in absorbance seen for many 
biologic media as seen in FIGURE 1. The bounds of this window consist of oxygenated 
and deoxygenated hemoglobin increasing in absorbance at the visible end of the window 
and water increasing at the infrared end. This indicates not only will minimal absorbance 
be seen in this window but maximum transmission as well. Utilizing the LSPR effect within 
the range of the therapeutic window allows for optimal excitation of GNPs with minimal 
damage to other tissue. Studies have shown the use of GNPs in this way for the treatment 




FIGURE 1 The near-infrared window from 650-900 nm with minimal absorbance of 
biologic materials (Weissleder, 2001) 
 
To enhance the abilities of GNPs various studies have looked at the potential of 
forming functional layers on the exterior of the gold surface. Conjugation of GNPs with a 
variety of molecules has been researched. The high affinity binding of sulfhydryl, or thiol, 
groups for gold surfaces, has been heavily exploited to allow for coating with thiolated 
molecules such as polyethylene glycol, DNA, or RNA (Ghosh 2008). Through 
functionalization with these molecules the particles can become more resistant to 
aggregation, self-assemble to form larger structures such as lattices, or serve as vectors for 
gene or drug delivery (Witten 2008, Delong 2010). Characterization of DNA-
functionalized spherical GNPs has been reported rather extensively utilizing techniques 
including SEM imaging, optical spectroscopy, dynamic light scattering, and 
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electrophoresis. Additionally, drug release from coated spherical GNPs has been studied 
both with and without in vitro cell studies analyzing cytotoxicity. However, most of this 
research has been done using spherical GNPs (Delong 2010). The use of gold nanoplates 
in this manner has much fewer reports but the approach in principle is identical. 
DNA aptamers are functional structures composed of nucleotides or peptides to 
bind to specific molecules or enzymes. They are similar in action to antibodies, which can 
inhibit signal pathways or signal for immune response to cancer cells, using a key-and-lock 
type site of recognition. Aptamers, being composed of nucleotides or peptides, can still 
bind to surface receptors but can also disrupt transcription and translation processes. One 
molecule that has already shown great promise as a standalone cancer treatment is the DNA 
aptamer AS1411 (Bates 2009). The sequence, discovered and developed by Bates et al., 
consisting of a guanosine-rich oligonucleotide chain that has been shown to form 
quadruplex structures known as G-quartets, as seen in FIGURE 2, which can have protein 
binding properties. Physiologically these structures have shown several unique 
characteristics that give them great potential as a chemotherapeutic agent. While AS1411 
exhibits decreased vulnerability to nuclease activity, increased uptake by cancer cells, and 
anti-proliferative effects the mechanisms of action for the molecule has been and continues 
to be studied. The current understanding of the mechanism concludes that nucleolin protein 
is displayed primarily on the surface of cancer cells, while only in the nucleus of healthy 
cells. AS1411 binds to nucleolin on the surface, which allows for internalization of the 
nucleolin-AS1411 complex. The AS1411 then causes further disruption to nucleolin 
dependent pathways linked to normal cancer progression. In vitro studies have shown 
AS1411 effective in treating a variety of cancer types across different cell lines. Initial 
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clinical trials have been performed showing no adverse effects while proving effective in 
stabilization or even complete response. Further clinical testing is underway and the study 
of the mechanisms involved continue to advance. 
 
FIGURE 2 Quadruplex conformation of G-rich oligonucleotide allowing for aptameric 
interaction with cell proteins (Bates 2009) 
 
Another functional DNA molecule that has been studied extensively is the stem 
loop, or hairpin. By controlling the sequence of nucleotides on a single DNA strand self-
complementary segments can be arranged. When allowed to fold these segments bind to 
each other through traditional Watson-Crick base pairing, creating a double stranded 
structure from a single DNA strand as seen in FIGURE 3. Using this type of automatic 
folding can yield complex structures with multiple loops as well as simple short sequences 
with a single loop. Hairpins have been applied as molecular beacons, suppressors of 
polymerase chain reactions, high-sensitivity probes, and drug carriers (Walter 1998, 
Broude 2002). Chemotherapeutic agents that intercalate between the base pairs of double-
8 
 
stranded DNA can be loaded into the stem region of the hairpin. Extreme changes in the 
environment such as temperature, pH, or salt concentration causes destabilization of the 
base pairing and denaturing of the hairpin structure. Using this effect the hairpin can be 
used as a selective release vehicle of active drugs. 
FIGURE 3 Hairpin, or stem loop, structure. Intercalation of doxorubicin into occurs in C-
G rich regions. 
 
Doxorubicin is a common chemotherapy drug from a family known as 
anthracyclines, and FIGURE 4 shows its chemical structure. It can be used for many types 
of cancer and is often included in combination with other chemotherapeutic agents. 
Delivery of doxorubicin is typically intravenous and can be aided by pegylation and/or 
encapsulation in liposomes (Tacar 2013). Systemic exposure to doxorubicin can cause fatal 
toxicity to the heart as well as significant toxicity to the brain, liver and kidneys (Chatterjee 
2010). Due to these side effects the dosage of doxorubicin must be limited and other 
additional therapies must be employed. A more selective release of doxorubicin would 
reduce these side effects while still allowing for cancer cell destruction. The method of 
action of doxorubicin is generally through intercalation with DNA and DNA-associated 
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enzymes (Tacar 2013). This causes the halting of replication and transcription, effectively 
halting cell proliferation, while also producing free radicals that cause further damage to 
DNA and protein production. A secondary effect of these disturbances is the reduction in 
cellular energy production and initiation of autophagy. Multiple other chemical pathways, 
such as AMP-activated protein kinase and Bcl-2/Bax, are inhibited or activated by 
doxorubicin and are known to control programmed cell death, or apoptosis (Tacar 2013). 
.  
 
The double helix structure of DNA, with major and minor grooves and stacked base 
pairs, allows for the binding of many different molecules. In the case of doxorubicin the 
binding occurs due to the ability of the aromatic rings to generate a pi-stacking arrangement 
between consecutive bases while the amine group remains within the minor groove. 
Optimal binding has been found to occur in regions rich in cytosine-guanosine base pairs 
as shown in FIGURE 3, specifically with repetition of the sequence CGATCG (Frederick, 
FIGURE 4 Chemical structure of Doxorubicin (Agudelo 2014) 
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1990). Using a DNA hairpin in this manner acts as a biocompatible carrier for doxorubicin 
with the ability to denature with increases in temperature, thereby releasing the drug.  
C. Objective 
The objective of this work is to produce a versatile and selective vehicle for the 
delivery and release of chemotherapeutic agents to the site of cancer cells. The overall 
process is depicted in FIGURE 5. Utilizing the previously mentioned Diasynth method to 
obtain gold nanoplates, a drug delivery vehicle is created through the use of single stranded 
DNA molecules and an intercalating drug, doxorubicin. Release of doxorubicin is induced 
via nIR laser application to heat gold nanoplates and denature the hairpin DNA. The 
synthesis and processing of this vehicle is detailed as well as testing to quantify the 
doxorubicin loading capacity, the bulk solution temperature during laser application, and 






FIGURE 5 A. Conjugation of DNA oligonucleotides to gold nanoplate surface. B. 
Loading of doxorubicin into the DNA hairpin. C. Laser induced release of doxorubicin. 
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II. MATERIALS AND METHODS 
A. Instrumentation 
All absorbance spectra were measured on a Varian (Palo Alto, CA) Cary 50 Bio 
UV-Vis Spectrophotometer using 12 mm quartz cuvettes and at a 10x dilution in Nanopure 
water, unless otherwise stated. Zeta potential and particle sizes (Dynamic Light Scattering, 
DLS) were measured using a Malvern Instruments (Worcestershire, United Kingdom) 
Zetasizer Nano ZS90, at a 10x dilution unless otherwise stated. Fluorescence was measured 
with a Turner Biosystems (Promega, Madison, WI) Modulus Fluorometer using the green 
fluorescence module accessory and glass microcell cuvettes with all readings being 
undiluted unless noted. The laser used for heating of the particles was a Coherent Inc (Santa 
Clara, CA) FAP System Model with a fixed emission wavelength of 817 nm and variable 
power setting. Actual laser power was measured before lasering using a Coherent FieldMax 
II-TO. The temperature of the solution while lasering was measured using an Omega 
Engineering (Stamford, CT) Thermocouple Data Logger (OM-EL-USB-TC-USB) and 
Omegasoft Data Logger Software (Rev. 6.8) using the provided type K thermocouple.  
B. Reactants 
The gold salt used was hydrogen tetrachloroaurate-III trihydrate (HAuCl3*3H2O) 
purchased from Alfa Aesar (Ward Hill, MA 01835). A 1.76 mM solution was prepared by 
dissolving 1 gram in 14.725 L of DI water in a volumetric flask protected from light with 
aluminum foil. Sodium thiosulfate pentahydrate (Na2S2O3*5H2O) was purchased from 
Sigma-Aldrich (St. Louis, MO) and 186.1 mg was used to create a 250 mL solution at 3 
mM. Oligonucleotides were purchased from Integrated DNA Technologies (Coralville, IA) 
and dissolved in Nanopure water to create stock solutions between 10 and 1 uM. See 
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TABLE 1 for oligonucleotide specifications. Dithiothreitol (C4H10O2S2) at 1 M 
concentration in H2O and dry powder doxorubicin hydrochloride (C27H29NO11*HCl) were 
purchased from Sigma-Aldrich (St. Louis, MI 63103). 
 
 
TABLE 1: OLIGONUCLEOTIDE SPECIFICATIONS 
DNA Modifiers Conformation Melting 
Temperature (oC) 
Extinction 
Coefficient at  
260 nm  
(L/(mol-cm)) 
Hairpin 3’ Thiol Hairpin/Stem 
Loop 
69.7 453,600 
Sequence: 5’-AGC TAG CGC TAG CGC TAG CTT TTG CTA CGC CTA GCG CTA 
GCT TTT TTT TTT /3ThiolMC3-D/ -3’ 
AS1411 5’ Thiol Quadruplex 67.0 298,000 
Sequence: 5’- /5ThiolMC6-D/TTT TTT GGT GGT GGT GGT TGT GGT GGT GGT 
GG -3’ 
 
C. Gold Nanoparticle Synthesis 
 GNPs were synthesized using the Diasynth process (Patel 2012) and reaction 
parameters were chosen to yield particles with maximum absorbance at approximately 820 
nm (James 2013) to match the wavelength at which the laser emits. Both temperature and 
surface area to volume ratio of the membrane can be varied to tune the maximum 
wavelength absorbance. The dialysis tubing cellulose membrane used was 43 mm wide 
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and had a 12 kDa molecular weight cutoff, purchased from Sigma-Aldrich and stored in 
DI water in a refrigerator at 4oC. Before use each membrane is cut to size and rinsed 
thoroughly with DI water. A membrane of 12 cm is taken and clipped on one end with a 
plastic dialysis clip. Then 32.6 mL of 1.76 mM gold salt solution is added followed by 
quickly adding 7.4 mL of 3 mM sodium thiosulfate solution and agitating for 5 seconds. 
The membrane is then clipped on the other end while minimizing air bubbles within the 
membrane, giving a final effective membrane length of 10 cm. The closed membrane is 
then submerged in a bath of DI water of at least 25 L circulated and maintained at 27oC by 
a Thermo (Waltham, MA) NESLAB RTE-221 Circulator. After reacting for 1 hour the 
membrane is removed and the solution is emptied into a 40 mL plastic tube. The UV-Vis 
spectrum of the product is analyzed to verify the peak absorbance wavelength, and size 
(DLS) and zeta potential are also measured.  
 
D. Oligonucleotide Preparation 
 Lyophilized oligonucleotides were used to create stock solutions in Nanopure 
water. Using the provided molecular weights as provided by the supplier, 10425.9 g/mol 
and 15839.4 g/mol for AS1411 and Hairpin respectively, 7.7 uM and 5 uM solutions were 
created respectively. Each oligonucleotide solution is stored in 4 oC with the thiol 
modification containing a disulfide bond. To become activated the disulfide bond must be 
broken to form a sulfhydryl that will readily react with the gold surface. For this 
dithiothreitol, DTT, is used to cleave the disulfide bond, requiring each DNA solution react 
in 0.1 M DTT concentration for at least 1 hour. Immediately prior to deprotection the DNA 
is exposed to a sodium phosphate buffer (PB) environment, at 0.18 M (pH 8), and heated 
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to 90oC, well above the melting temperature of the DNA strands, and then allowed to cool. 
A salt concentration, provided by the buffer, is needed to provide the proper base pairing 
of DNA. Annealing in this way denatures the DNA and then allows it to fold in the presence 
of the buffer ensuring folding before bonding to the gold. To obtain the purified, activated 
oligonucleotides the excess DTT must be separated using a chromatography column. Using 
GE (Buckinghamshire, United Kingdom) illustra NAP-25 columns and 10 mM PB (pH 8) 
as the mobile phase the two oligonucleotides are eluted. Each sample of oligonucleotide is 
then analyzed with UV-Vis spectroscopy to determine the absorbance at 260 nm which 
correlates to the concentration of DNA by using the manufacturer-supplied molar 
absorptivity for each strand of DNA. 
E. Functionalization of Gold Nanoplates with DNA 
 Once the oligonucleotides are separated from the DTT via the chromatography 
columns, addition of gold particles must take place within a short period of time. Once the 
DTT is removed the activated sulfhydryl groups on the oligonucleotides can reform 
disulfide bonds with each other. If the solution is allowed excess time in this state they 
would not be able to bond to the surface of the gold and effectively give no coating of the 
gold particles. Therefore, at this stage only thirty minutes is given between isolation of the 
oligonucleotides and mixture of the gold nanoparticle solution with DNA. For every batch 
of DNA-coated particles the following samples are created: GNPs with hairpin, GNPs with 
AS1411, and GNPs with both hairpin and AS1411. The sample with both hairpin and 
AS1411 molecules used an equal ratio of each oligonucleotide and each was added 
simultaneously to the gold solution. The calculations used to determine the volumes of 
each reactant to add to create said particles used the Beer-Lambert Law and the definition 
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of molarity. Given the absorbance, extinction coefficient, and volumes of each reactant the 
number of molecules available can be determined. The extinction coefficients of the 
oligonucleotides is provided by the supplier and although the precise parameter for the 
GNPs has not been determined. Studies have shown spherical nanoparticles of silver and 
gold to have similar extinction coefficients on the order of 109 to 1010 L/mol-cm (Navarro 
2013). Due to the significantly lower volume of similarly sized plates the lower end of this 
estimation was used. Variation in this parameter ultimately only becomes a factor when 
looking at exact loading efficiencies, as any ratio of nanoplates to oligonucleotides will get 
some degree of coating. The limiting reactant can be determined and then used to calculate 
the volumes to add to create the three samples as mentioned. For this study a ratio of 1120 
oligonucleotides per gold nanoparticle was used to ensure sufficient loading of DNA. It 
has been shown in previous studies, and is suggested here, that uncoated gold nanoplates 
are sensitive to aggregation from exposure to salt (Guo 2010). The oligonucleotide 
solutions are at a 10 mM PB concentration when added to the gold solution and is then 
diluted to 5 mM with the addition of Nanopure water. Additionally, irreversible 
aggregation of GNPs onto the walls of containers was also mitigated by the use of low 
DNA-binding tubes, such as Lobind Eppendorf (Hamburg, Germany) centrifuge tubes. All 
further processes were done with all samples in parallel unless otherwise noted. 
 After combining the appropriate volumes of gold and oligonucleotides the samples 
are incubated at 4 oC and vortexed every thirty minutes for the first three to four hours and 
then further incubated at 4 oC overnight. On the next day the excess DNA is removed 
through serial centrifugations and washings. Centrifugation was performed using a 
Beckman Coulter (Brea, CA) Microfuge 16 set at 2500 xg for 4 minutes. The resulting 
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colorless supernatant was collected and the pellet was resuspended in 5mM PB solution. 
The sample was then sonicated with a Misonix (Farmingdale, NY) Microson XL 2000 
sonication probe 10 times in 1 second bursts and vortexed to fully resuspend any particles. 
This centrifuging, supernatant removal, and resuspension is performed three times for each 
sample. After this stage each sample and corresponding supernatant is analyzed by UV-
Vis spectroscopy, DLS, and zeta potential measurement. 
F. Loading Doxorubicin Into Hairpin 
 A 100 uM solution of doxorubicin hydrochloride was created from dry power by 
dissolving 0.3 mg into 5 mL of Nanopure water and a fraction of this stock was taken and 
diluted to 10 uM for addition to GNP-DNA particles. Previous studies of doxorubicin 
loading at a concentration of 5 uM for 300 nM DNA hairpin showed saturation of the 
hairpin at 4 doxorubicin molecules per hairpin (Luo 2011). Due to the decreased stability 
of the gold nanoplates in high salt concentrations, to which doxorubicin hydrochloride 
contributes, the concentration of doxorubicin used to load the particles was limited to 0.5 
uM. This will not provide saturation of the hairpin but will still allow for some loading of 
dox and provide a measurable fluorescence upon release. Maximizing dox loading is not 
crucial for proof of concept and preventing aggregation of the particles is crucial to further 
testing. To load the particles with doxorubicin a GNP-DNA sample is diluted to an 
absorbance, or optical density (OD), of 3 with a doxorubicin concentration of 0.5 uM using 
5 mM PB as needed for dilution. For this step only GNPs with hairpin and GNPs with 
hairpin and AS1411 were used as GNPs with AS1411 have no ability to intercalate with 
dox, as it does not have repeating C-G bases or traditional base pairing to provide the pi 
stacking arrangements. These samples were allowed 2 hours to react at room temperature, 
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approximately 26°C. To remove excess dox the samples were centrifuged and washed in a 
manner analogous to the DNA loading protocols. Centrifugation was performed at 1000 
xg for 2 minutes or 4 minutes if no aggregation was seen. The largely colorless supernatant 
was collected leaving a purple pellet that is then resuspended with 5 mM PB and vortexed. 
This process is performed up to 3 times if no aggregation occurs but was done twice in 
some cases to prevent significant loss of particles due to irreversible aggregation. 
Aggregation in previous samples was marked by loss of SPR bands, size analysis showing 
several fold increase, and zeta potential readings approaching zero. Visibly these changes 
were coincident with rapid change in color, from purple to blue or gray, and the collection 
of gray film or particulates on tube walls. Supernatants are analyzed for fluorescence to 
determine the amount of dox present, which can be used to estimate the number of hairpin 
particles present on the GNPs. The resulting particles are now GNPs functionalized with 
hairpin or hairpin/AS1411 oligonucleotides intercalated with doxorubicin. These samples 
are then analyzed for UV-Vis spectra for particle content and absorbance at 817 nm. 
E. Laser-induced Release of Doxorubicin 
Using the nIR absorbance peak obtained from the UV-Vis spectrum the samples are diluted 
to 0.5 OD and a volume of 0.5 mL using Nanopure water. Before laser application each 
sample is then analyzed for fluorescence along with a control, which has not been loaded 
with dox, similarly diluted from the same batch of functionalized particles. A fluorescence 
measurement was taken 3 times for each sample. In turn each sample was dispensed into a 
48 well plate and heated with a laser. The 817 nm wavelength laser was set to 8200 mA 
(1000 mW) and emitted 21 cm above the target. The laser area consisted of a circle with a 
diameter of 1.25 cm covering the well fully. The actual laser power at the well plate was 
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measured with a Coherent Laser Power Meter as approximately 800 mW. Duration of laser 
application was 5 minutes followed by immediate collection and centrifugation at 1000 xg 
for 2 to 4 minutes, matching the washing setting used to wash the sample in the dox loading 
process. The supernatant was collected and the pellet resuspended to 0.5 mL with Nanopure 
water and vortexed briefly. This process is performed 3 times to obtain a release profile of 
doxorubicin. Temperature is also measured during laser application using an Omega 
thermocouple probe and USB data logging device. After the final centrifugation and 
supernatant collection the 3 collected supernatants are centrifuged at 1000 xg for 4 minutes 
to pellet any coincident gold in solution. Then 200 uL from the top of each supernatant is 
analyzed for fluorescence, taking 3 measurements per sample. This procedure is done for 
3 replicates of dox loaded and control samples of GNPs with hairpin and GNPs with hairpin 







III. RESULTS AND DISCUSSION 
A. Gold Nanoparticle Synthesis 
 GNPs were produced using the Diasynth method and expected to contain a large 
fraction of plates, comparatively few spheres, and with a controllable SPR band within the 
NIR range. The spectrum of a sample used for subsequent functionalization, dox loading, 
and lasering are presented in FIGURE 6.The UV-Vis absorbance spectra show favorable 
SPR bands that will absorb highly within the therapeutic window and at the 817 nm 
wavelength of the available laser. The ratio of NIR band to 530 nm band can also 
approximate the ratio of plates to spheres. As nanospheres only exhibit SPR bands in the 
visible region and nanoplates exhibit in the nIR region these two can be easily 
differentiated within a spectra measurement. Typically the nIR peak should be 2 times as 
large as a 530 nm peak for a composition consisting of mainly plates (Patel 2012). The size 
for the nanoplates, identified as contributing to the majority of intensity readings from 
DLS, was found to be 68.46 nm on average, with a standard deviation of 2.74 nm. The 





FIGURE 6 UV-Vis spectrum of representative gold nanoparticles synthesized using the 
Diasynth method. The two peaks approximate the ratio of spheres and plates. Absorbance 
in therapeutic windows indicates suitability for laser absorption. 
 
Synthesis of GNPs using the Diasynth methods as described previously produced 
particle with SPR bands controllable through variation in temperature and dialysis 
membrane length. Other variations in the reactants such as supplier and duration in solution 
seem to cause changes in this response giving a variation in absolute characteristics but 
maintaining relatively predictable synthesis outcomes. Through iterative refinement of the 
optimal temperature and membrane length the SPR peak was tuned to obtain the particles 
detailed above. For the purposes of this research the spherical particles act as a 
contaminant, and theoretically should be functionalized in subsequent steps, while the 
practical focus is on the nanoplates. With further research into the characteristics, 
interactions, and application of gold nanoplates the isolation and processing of these 


























Bare GNPs from Diasynth
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wavelength laser at the wavelength of max absorption for the plates is assumed to 
effectively only significantly heat the nanoplate population. 
 
B. Functionalization of GNPs with DNA 
 The success of coating the GNPs with DNA was to be confirmed through change 
in the size and zeta potential of the particles. As shown in TABLE 2 the size increases 
across all samples after reacting with the oligonucleotides. The average size increase is 
23.5, 42.23, and 26.13 nm for GNP-Hairpin, GNP-AS1411, and GNP-Hairpin-AS1411 
respectively, with GNP-AS1411 having the highest standard deviation at 23.9 nm. Zeta 
potential had more consistent data across samples with the average change in potential of 
-11.90, -11.40, and -9.52 mV respectively, with the highest standard deviation being 2.47 
mV. Analysis of the variance (Appendix Ia.) showed that there was a significant difference 
in size between bare and coated particles at a 95% confidence level, while coating mixture 
was not a significant factor. Similarly, it shows a significant difference at a 95% confidence 
level in zeta potential for bare and coated particles but found the type of coating not a 










The overall trend that points to successful binding is the significant but small 
increase in size. This is as one would expect as the physical size of the complex is 
increasing with the addition of oligonucleotides onto all sides of the particle. Assuming a 
length of 0.33 nm per base (Mandelkern, 1981) the single stranded hairpin and AS1411 










GNP-Hairpin-1 70.40 95.66 25.26 -30.8 -44.15 -13.35 
GNP-Hairpin-2 70.40 100.55 30.15 -30.80 -44.10 -13.30 















GNP-AS1411-1 70.40 85.63 15.23 -30.80 -40.25 -9.45 
GNP-AS1411-2 66.52 127.3 60.78 -32.15 --46.40 -14.25 















GNP-Hairpin-AS1411-1 70.40 94.7 24.3 -30.8 -40.70 -9.90 
GNP-Hairpin-AS1411-2 66.52 99.22 32.70 -32.15 -41.95 -9.80 
















TABLE 2 SIZE AND ZETA POTENTIAL OF DNA-FUNCTIONALIZED GNPS 
24 
 
would be 16.83 nm and 10.56 nm respectively. After folding into their respective structures 
of double strand and quadruplex they would then be approximately 8.42 nm and 2.64 nm. 
Binding of these structures onto each side of the nanoparticle would then increase the 
overall size by at least 16 nm and 5 nm respectively. The possibility of crosslinking 
multiple oligonucleotides through base pairing or other interactions is an area of further 
research, but could create larger size increases. Additionally, the DLS reading perceives 
the hydration sphere of the particle taking into effect the interaction with water, thus 
increasing the apparent size of charged particles. Alternatively, any irreversible 
aggregation would be expected to increase the size much more dramatically and bring the 
zeta potential toward zero.  
The UV-Vis spectra as seen in FIGURE 7 shows a set of coated particles that 
maintain a high SPR peak in the nIR range. This is crucial to the success of the particles as 
a large shift away from the laser frequency or a loss in absorbance would reduce the 
efficacy of these particles to heat with 817 nm laser application. The spectra changes 
associated with coating of the particles seems to vary little between coating composition 
and depends more on the source bare GNPs . This could include affinity for aggregation 
and presence of spherical particles. As mentioned previously the resulting particles do have 









The procedure for functionalizing GNPs with oligonucleotides was taken from one 
study using similar approaches working with gold nanospheres (Luo 2011). The main 
difference between this study and those previously is that gold nanospheres have shown 
much more stability to the addition of salt where gold nanoplates tend to aggregate (Fan 
2010). This is likely due to the geometry providing less uniform repulsion allowing for 
closer approach of plates along the planar faces leading to stacking. It has also been shown 
that the loading of DNA onto GNPs can be achieved through slow incremental increase in 
the salt concentration as high as 0.7 M NaCl for absolute maximum packing (Hurst 2006). 
FIGURE 7 UV-Vis spectra of DNA-coated GNPs. The peaks shift slightly but maintain 




SIZE AND ZETA POTENTIAL OF AGGREGATED DNA-FUNCTIONALIZED GNPS 
However a portion of DNA will still bond to the particle surface without significant 
addition of salt. The occurrence of aggregation from salt addition or other incidental 
processes caused a visible change in the solution from a dark purple to blue or gray with 
eventual colorlessness and gray or black large particulates settling and adhering to the tube 
surface. This reaction can also be surmised from DLS measurements, showing a size 
change from less than 100 nm to several hundreds of nanometers as shown in TABLE 3, 
and UV-Vis spectra, shifting from a strong peak to a low broad absorbance with no 
discernable peak as seen in FIGURE 8. Due to the sensitivity of the nanoplates to high salt 
concentration, further processing was done with no additional salt added beyond the 
maintenance of a 5 mM PB concentration. Possible methods of stabilization include 
capping agents, such as citrate, or coatings of long hydrophilic chains, such as polyethylene 
glycol. Such changes must be taken into consideration for the overall effect on the further 
processing and performance of the particles as these changes could have effects on the 








 Particle Size (nm) 
 Bare DNA-coated 
GNP-Hairpin 86.16 407.65 
































FIGURE 8 UV-Vis spectra of aggregated DNA functionalized GNPs. No substantial NIR 










Despite attempts at quantification the amount of DNA loaded onto the GNPs could 
not be directly quantified at this time with the available reactants and analysis tools. 
Theoretically the 260 nm absorbance of supernatants from the washing of GNP-DNA 
particles would contain only absorbance from unbound DNA. However, this proved to be 
unrealistic as absorbance appeared higher than that of the DNA. This impossibly high 
reading indicated some other 260 nm absorbing particles, pointing to spherical gold 
remaining in the supernatant. Similarly, attempting to strip bound DNA from coated 
particles showed the same problem. DTT was used to break the thiol bond and release the 
DNA followed by centrifugation to pellet the GNPs while leaving the DNA in the 
supernatant. Again a second contributing factor appeared to be absorbing at 260 nm in 
addition to the DNA. However, because the previous study achieved saturation of this same 
hairpin, at 4 dox molecules per oligonucleotide, the number of hairpins can be estimated 
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from the quantification of dox loading. This is easily determined through fluorescence and 
is covered more extensively in subsequent sections. 
 
B. Loading Doxorubicin into Hairpin 
After confirmation of DNA binding to the GNPs the hairpin molecules were loaded 
with dox for later release. As mentioned previously, attempts to use the concentration of 
dox found in other established protocols (Luo 2011) lead to aggregation of the particles 
due to high salt concentration. Therefore a reduced concentration of dox was used for 
loading. The analysis of the particles after loading and washing saw some decreases in 
overall quality of the nIR peak but not as severe as seen with aggregation. Additionally, 
during processing the visible color of the particles remained constant and minimal 
adherence to the tube walls was seen. FIGURE 9 shows a spectrum of a sample at this 





Dox loading was quantified indirectly by measuring the fluorescence of the wash 
supernatants. Using the raw fluorescence measurements and a fluorescence calibration 
curve (see Appendix 1D) for dox the concentration of dox in the supernatants can be 
determined. With an initial concentration of 0.5 uM dox added during loading the dox 
concentration in the supernatant is assumed to be the difference between initial 
concentration and the loaded concentration. From this relationship the amount of 
successfully loaded dox can be calculated followed by total molecules of dox given the 
volume of supernatant. Then the known absorbance of loaded particles at 820 nm can be 
used again with the Beer-Lambert equation to determine the total number of nanoplates 
FIGURE 9 UV-Vis spectra of GNP-Hairpin-AS1411 loaded with dox. Aggregation 




present in the volume of loaded particles. The number of dox molecule and gold nanoplates 
in the final sample have been found and can be used to find the number of dox per 
nanoplate. Conservatively assuming 1 molecule of dox per hairpin molecule, as Luo et al. 
found previously a saturation of 4, the number of hairpins per gold nanoparticle can be 
calculated. The number of oligonucleotides per plate estimated from dox loading is detailed 
in TABLE 4. 
TABLE 4  
NUMBER OF HAIRPIN OLIGONUCLEOTIDES PER GOLD NANOPLATE 
Sample GNP-Hairpin GNP-Hairpin-AS1411 
Replicate 1 369.6 370.5 
Replicate 2 383.5 385.5 
Replicate 3 385.4 386.3 







These results indicate a reasonable number of oligonucleotides, considering the 
indirect nature of the calculations. Because the hairpin-AS1411 sample is reacted with half 
the quantity of hairpin as the hairpin-only sample one would expect a noticeable decrease 
in dox loading capabilities but this is not seen. The difference between samples is relatively 
small potentially meaning that hairpin binding is preferential to AS1411 binding. 
Regardless of this difference there is evidence that there is loading of dox onto the hairpins 
which is crucial to the later release study. 
This indirect type of quantification is not ideal but can serve at least as a check for 
sufficient dox washing. Seeing values indicative of high dox concentrations in supernatants 
would mean that free dox could still be in high concentration around the loaded particles. 
Assumptions inherent in this method of determining DNA loading include the previously 
31 
 
mentioned extinction coefficient of gold nanoplates, relatively little interference of 
fluorescence by any gold nanospheres, and sufficient washing in previous steps. The 
theoretical physical limit of DNA loading can be approximated using surface area for a 
plate with edge length of 70 nm, thickness of 2 nm, and the diameter of a double helix of 
2 nm (Mandelkern, 1981). This could give a plate total surface area of 7000 nm2, and at 
90% efficient hexagonal packing a maximum of 500 oligonulceotides per gold nanoplate. 
To better quantify the DNA loading other studies have used fluorescently labeled 
oligonucleotides and a similar approach could be used for further study of the loading 
characteristics of these particles. 
C. Laser-induced Release of Doxorubicin 
 After loading the particles with dox the samples were exposed to laser light, at 817 
nm wavelength, a power of 800 mW, and duration of 5 minutes. The particles were then 
removed via centrifugation, and the amount of free dox in the supernatants quantified 
through fluorescence measurements. The samples showed a consistent release pattern 
despite some variations likely due to the salt sensitivity of the complexes. The average 
fluorescence reading after each lasering can be seen in FIGURE 10 for GNP-Hairpin and 
FIGURE 11 for GNP-Hairpin-AS1411. Also shown are the fluorescence readings from 
control GNP-DNA particles without dox that were lasered and processes in the same way. 
The percentage that each laser application contributed to the total release is also 
represented. The average fluorescence reading for the GNP-Hairpin particles is 336.6, 
227.4, and 167.6 FSU for the first, second, and third laser applications respectively. 
Meanwhile the control registered 140.1, 140.3, and 136.2 FSU for the same points. The 
GNP-Hairpin-AS1411 particles were a bit lower at 197.1, 155.4, and 142.9 FSU, with its 
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control at 139.9, 129.2, and 128.1 FSU. The analysis of the variance of these results showed 
that significant factors at 95% confidence include laser number, loaded or non-loaded, and 
GNP-Hairpin or GNP-Hairpin-AS1411. This indicates that these all indeed effect the 
amount of dox released.  
 
 
FIGURE 10 Fluorescence readings of supernatants from lasered GNP-Hairpin samples 
loaded with dox. The first laser releases the most dox and subsequent lasering approaches 




FIGURE 11 Fluorescence readings of supernatants from lasered GNP-Hairpin-AS1411 
samples loaded with dox. The first laser releases the most dox and subsequent lasering 




These results indicate that there was a release of dox due to the laser application 
and that the first laser application releases most of the dox. Analysis of the variance 
(Appendix I B) showed a significant difference between the dox loaded and control 
samples, and also indicated that the effects of laser number and coating type were 
significant to fluorescence measurement. This effectively serves as proof of concept that 
the particles do behave as proposed to serve as a possible vehicle for delivery and release 
of doxorubicin. One possible factor biasing these results could include the methodology of 
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collecting the free dox after each lasering. The above results could be a symptom of dilution 
due to centrifugation and resuspension in the process thus showing fluorescence 
approaching the control. This is possible but should be mitigated by sufficient washing of 
excess dox during the loading phase. This specific possibility could be further studied by 
modifying the washing process, to more thoroughly ensure excess dox removal, and then 
release the dox with lasering to compare the results. 
  
The other measurement taken during lasering was bulk solution temperature, seen 
in TABLE 5. All samples saw heating exceeding that of water with a maximum 
temperature of 58oC and minimum of 37.5oC. The overall average was 46.3±7.6oC for 
particles loaded with dox and 43.4±3.7oC for particles with no dox. Analysis of the variance 
(Appendix I C) showed that there was no significant difference in the maximum 
temperature reached for any factor differentiating samples, including DNA coating, dox 


















These findings confirm that all samples were heated nearly the same while the 
variation could not be attributed to one particular factor. This likely means that any 
variation comes from processes in the production of the coated GNPs or even the 
production of the bare particles. Ultimately it is most important that the gold particles be 
heated enough to denature the hairpin structure to allow dox to be released. However the 
bulk temperature read here is not seen to be above 60oC, well below the melting 
temperature (TM) of the hairpin at 69.7
oC. The important realization here is that the local 
heating at the particle surface induced by the SPR effect is effectively dampened by the 
large volume of water into which the heat has to dissipate, and therefore oligonucleotides 
conjugated to the particle surface likely experience greater thermal fluctuations compared 
to the bulk solutions. One study found the bulk temperature induced by this effect to be as 
high as 100 oC (Gobin 2010). This is also confirmed by the fact that despite bulk temperate 
 Maximum Temperature (oC) 
Sample Laser 1 Laser 2 Laser 3 
GNP-Hairpin-Dox 1 54 54.5 51 
GNP-Hairpin-Dox 2 43.5 37.5 34 
GNP-Hairpin-Dox 3 54.5 48 45 
GNP-Hairpin-1 45 41 37.5 
GNP-Hairpin-2 52 48 45.5 
GNP-Hairpin-3 45 40.5 38 
GNP-Hairpin-AS1411-Dox 1 40.5 40 38 
GNP-Hairpin-AS1411-Dox 2 43 40.5 40.5 
GNP-Hairpin-AS1411-Dox 3 58 57 53.5 
GNP-Hairpin-AS1411-1 45 44 40.5 
GNP-Hairpin-AS1411-2 47 43 39.5 
GNP-Hairpin-AS1411-3 45 44 40.5 
Water 27 26 26 
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of the solution being lower than the TM for the hairpin, significant dox release is still seen, 
which means that hairpin must be denaturing. The ability to effectively achieve hairpin 
denaturation and dox release at bulk temperatures near 43oC is very useful in a practical 
sense for achieving hyperthermic ablation of cancer cells without causing significant heat-
related damage to surrounding tissue (Kobayashi 2011). This data is also useful for future 
studies in correlating bulk temperature to the amount of dox released over time, with 
temperature being an easily measurable metric.   
IV. FUTURE WORK 
The results presented here serve as a first look at the possibility of using gold 
nanoplates as a delivery system for multiple chemotherapeutic agents. Although the data 
presented here shows promise there is much left work to be done before any significant 
need can be met. Overall the data presented would benefit from more samples and 
refinement of the individual processes to further analyze the therapeutic potential of these 
particles. Other studies on the underlying processes of the related work, such as 
oligonucleotide packing on gold nanoplates or preferential binding of different 
oligonucleotides would also be greatly beneficial. Probably the most commonly found 
problem in this study was the aggregation of the gold nanoplates. This process has been 
studied with other GNPs but because not much has been done with pure nanoplates there 
is not much guidance for preventing aggregation. The methods and data presented here 
only represent a small subset of the potential ways of coating these particle, so it is very 
likely another method could cause less aggregation. A method of resisting aggregation in 
the presence of salt would allow for a much more controllable loading of oligonucleotides 
as mentioned previously. This would allow for a controllable maximum dox load to 
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simplify future studies looking at oligonucleotide loading, dox loading, or even needed 
therapeutic concentrations of particles. Precisely determining the extinction coefficient of 
gold nanoplates would allow for a more accurate calculation for the number of gold 
nanoplates in a given solution.  
The isolation of gold nanoplates or the synthesis of pure gold nanoplates is another 
thing that is currently being researched. As mentioned other techniques to analyze the 
loading of both DNA and dox would shed light on some of the possible hurdles encountered 
in this project. Ultimately, assuming continued interest and feasibility in this type of 
delivery vehicle, the next step after process optimization is live studies studying the 
efficacy of particles against cancer. This would include in vitro studies of cancerous and 
healthy cells, examining both cytotoxicity upon release to cancer and biocompatibility with 
healthy cells. Beyond that realm would be clinical studies in animals, and eventually 
humans, before being a new tool in the treatment of cancer. Even if that is not the final end 
point of this specific research it is sure to help the overall research into the possibilities of 
GNPs and nanoparticle drug delivery vehicles.  
V. CONCLUSION 
The work presented here has attempted to prove the potential of gold nanoplates 
coated with DNA oligonucleotides as a delivery vehicle for the controlled delivery of 
cancer drugs. GNPs with an SPR band in the nIR range were synthesized using the 
Diasynth method to preferentially separate nanoplates from nanospheres. The particles 
were then coated with two different DNA oligonucleotides with corresponding increases 
in particle size and more negative zeta potential. Doxorubicin was then intercalated into 
the attached DNA which was confirmed via fluorescence measurements. Laser induced 
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release of doxorubicin from DNA was shown in bench top tests through fluorescence 
measurements. 
Stability of gold nanoplates continues to be area in need of research as the optimal 
processing of these particles become ever more valuable. The processes presented here 
produced the proof of concept for these particles, but much room remains for optimization 
or modification. Further research into each aspect of the principles driving these reactions 
is needed to better quantify and understand these processes. Modification to enhance the 
abilities of these particles can also be explored as much work has already been done with 
gold nanospheres as drug delivery vehicles.  
After refining the synthesis process in vitro cell studies are the next step for testing 
the therapeutic potential of these particles. The promise of a selectively released 
chemotherapy drug with multiple molecules to treat cancer is a great improvement over 
traditional chemotherapy, greatly reducing the side effects while potentially increasing the 
efficacy. The ultimate potential of this research is ultimately the full production and use of 












A. DNA Loading Statistical Analysis 




Factor  Levels  Values 
Oligos       3  Hairpin, AS1411, 1to1 
Stage        2  Bare, DNA 
 
 
Analysis of Variance 
 
Source      DF  Adj SS  Adj MS  F-Value  P-Value 
Model        5  4692.4   938.5     8.48    0.001 
  Blocks     2   212.9   106.4     0.96    0.410 
  Linear     3  4479.5  1493.2    13.49    0.000 
    Oligos   2   259.8   129.9     1.17    0.342 
    Stage    1  4219.7  4219.7    38.12    0.000 
Error       12  1328.4   110.7 
Total       17  6020.9 
 
 
FIGURE 12 Residual plots for the size analysis of DNA loading 
 






Factor  Levels  Values 
Oligos       3  Hairpin, AS1411, 1to1 
Stage        2  Bare, DNA 
 
 
Analysis of Variance 
 
Source      DF   Adj SS   Adj MS  F-Value  P-Value 
Model        5  550.004  110.001    51.62    0.000 
  Blocks     2    8.584    4.292     2.01    0.176 
  Linear     3  541.420  180.473    84.69    0.000 
    Oligos   2    2.954    1.477     0.69    0.519 
    Stage    1  538.467  538.467   252.69    0.000 
Error       12   25.572    2.131 













B. Laser Induced Dox Release Statistical Analysis 




Factor           Levels  Values 
Dox                   2  Dox, No Dox 
Hairpin or 1to1       2  Hairpin, 1to1 
Laser number          4  0, 1, 2, 3 
 
 
Analysis of Variance 
 
Source                            DF  Adj SS  Adj MS  F-Value  P-Value 
Model                              8  216016   27002     5.21    0.000 
  Linear                           5  211649   42330     8.17    0.000 
    Dox                            1   84403   84403    16.29    0.000 
    Hairpin or 1to1                1   23223   23223     4.48    0.041 
    Laser number                   3  104022   34674     6.69    0.001 
  2-Way Interactions               3    4367    1456     0.28    0.839 
    Hairpin or 1to1*Laser number   3    4367    1456     0.28    0.839 
Error                             39  202022    5180 
  Lack-of-Fit                      7   45267    6467     1.32    0.273 
  Pure Error                      32  156755    4899 
Total                             47  418038 
 
 






C. Temperature Data Analysis 
 
Multilevel Factorial Design  
 
Factors:       3     Replicates:     3 
Base runs:    12     Total runs:    36 
Base blocks:   1     Total blocks:   1 
 
Number of levels: 2, 2, 3 
 
 




Factor  Levels  Values 
Dox          2  Dox, No Dox 
DNA          2  Hairpin, Hairpin-AS1411 
Laser        3  Laser 1, Laser 2, Laser 3 
 
 
Analysis of Variance 
 
Source         DF   Adj SS  Adj MS  F-Value  P-Value 
Model           4   279.74  69.934     2.15    0.099 
  Linear        4   279.74  69.934     2.15    0.099 
    Dox         1    75.11  75.111     2.31    0.139 
    DNA         1     6.25   6.250     0.19    0.664 
    Laser       2   198.37  99.187     3.05    0.062 
Error          31  1009.76  32.573 
  Lack-of-Fit   7    19.93   2.847     0.07    0.999 
  Pure Error   24   989.83  41.243 




FIGURE 15 Residuals for temperature analysis 
 
D. Doxorubicin calibration curve 
 
FIGURE 16 Fluorescence calibration curve for Doxorubicin 
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